<p>The tumor-bearing animal model was established by subcutaneous injection of H22 cells into Kunming mice. The control group and the test groups were administered intravenously with 20 mg/kg of 5-FA or 5-FA-PAE (equivalent to 20 mg/kg of 5-FA), respectively. The mice were exsanguinated and sacrificed at predetermined time points. Tissues (heart, liver, spleen, lung, kidney, brain and tumor) were collected, weighed and homogenized with two fold concentrated physiological saline. The samples of the test group were treated as hydrolyzed samples, whereas those of the control group were treated as unhydrolyzed samples. All data are presented as the concentration of 5-FA. Each value represents the mean ± standard deviation (n = 6).</p
<p>Amount of 5-FU in rat mammary tissues after topical (nipple), transdermal (breast skin) and intra...
<p>The percentage of the injected dose per gram of tissue (%ID/g) ± SD in the different organs, at t...
<p>The CT26 murine colon adenocarcinoma cell line was used to evaluate effect of 5-FU <i>in vivo</i>...
<p>The tumor-bearing mice model was described in the “<i>In vivo</i> biodistribution” section. The c...
<p>*<i>p</i><0.05 vs. saline group.</p><p>**<i>p</i><0.01 vs. saline group.</p>Δ<p><i>p</i><0.05 vs....
<p>Each value represents the mean ± SD (n = 12).</p><p>*<i>p</i><0.05 vs. 5-Fu,1 day before injectio...
<p><b>A</b>. Biodistribution of [<sup>18</sup>F]AlF-NOTA-P2-RM26 in male BALB/c nu/nu mice bearing P...
<p>Ratio of amount of 5-FU in rat organs or plasma (5-FU<sub>O/P</sub>) and amount of 5-FU in mammar...
<p>The biodistribution of <sup>18</sup>F-tLyP-1 is shown at 60 min and 120 min after injection (n = ...
<p>Mice (n =3) bearing s.c. PC3-luc tumors were injected with 1.85 MBq (50 µg) of <sup>125</sup>I-PG...
<p><b>A.</b> Biodistribution of <sup>64</sup>Cu-NOTA-TRC105 and <sup>64</sup>Cu-DOTA-TRC105 at 24 h ...
<p><sup>a</sup> Expressed as % injected dose. Each value represents the mean (SD) for four animals.<...
<p>(A) Drug release profiles of 5-FA-PAE in PBS and saline. 100 µl 5-PA-PAE was added to preheated r...
(A) Quantitative analysis of biodistribution of 18F-hyErbB2-idT and 18F-hyErbB2 at 30 min post-injec...
<p>Biodistribution of <sup>64</sup>Cu-CB-TE1A1P-LLP2A in 5TGM1 s.c. tumor mice (black bars). The ope...
<p>Amount of 5-FU in rat mammary tissues after topical (nipple), transdermal (breast skin) and intra...
<p>The percentage of the injected dose per gram of tissue (%ID/g) ± SD in the different organs, at t...
<p>The CT26 murine colon adenocarcinoma cell line was used to evaluate effect of 5-FU <i>in vivo</i>...
<p>The tumor-bearing mice model was described in the “<i>In vivo</i> biodistribution” section. The c...
<p>*<i>p</i><0.05 vs. saline group.</p><p>**<i>p</i><0.01 vs. saline group.</p>Δ<p><i>p</i><0.05 vs....
<p>Each value represents the mean ± SD (n = 12).</p><p>*<i>p</i><0.05 vs. 5-Fu,1 day before injectio...
<p><b>A</b>. Biodistribution of [<sup>18</sup>F]AlF-NOTA-P2-RM26 in male BALB/c nu/nu mice bearing P...
<p>Ratio of amount of 5-FU in rat organs or plasma (5-FU<sub>O/P</sub>) and amount of 5-FU in mammar...
<p>The biodistribution of <sup>18</sup>F-tLyP-1 is shown at 60 min and 120 min after injection (n = ...
<p>Mice (n =3) bearing s.c. PC3-luc tumors were injected with 1.85 MBq (50 µg) of <sup>125</sup>I-PG...
<p><b>A.</b> Biodistribution of <sup>64</sup>Cu-NOTA-TRC105 and <sup>64</sup>Cu-DOTA-TRC105 at 24 h ...
<p><sup>a</sup> Expressed as % injected dose. Each value represents the mean (SD) for four animals.<...
<p>(A) Drug release profiles of 5-FA-PAE in PBS and saline. 100 µl 5-PA-PAE was added to preheated r...
(A) Quantitative analysis of biodistribution of 18F-hyErbB2-idT and 18F-hyErbB2 at 30 min post-injec...
<p>Biodistribution of <sup>64</sup>Cu-CB-TE1A1P-LLP2A in 5TGM1 s.c. tumor mice (black bars). The ope...
<p>Amount of 5-FU in rat mammary tissues after topical (nipple), transdermal (breast skin) and intra...
<p>The percentage of the injected dose per gram of tissue (%ID/g) ± SD in the different organs, at t...
<p>The CT26 murine colon adenocarcinoma cell line was used to evaluate effect of 5-FU <i>in vivo</i>...